鉑科新材(300811.SZ):深交所恢復審核可轉債發行申請
格隆匯9月17日丨鉑科新材(300811.SZ)公佈,公司向不特定對象發行可轉換公司債券申請於2021年8月9日獲得深交所受理。
公司為該次發行聘請的律師事務所因其為其他公司提供的法律服務而被中國證監會立案調查,根據《深圳證券交易所創業板上市公司證券發行上市審核規則》第十九條、《深圳證券交易所創業板股票發行上市審核規則》第六十四條的相關規定,深交所於2021年8月18日決定對公司該次發行申請中止審查。
公司該次發行的律師事務所已根據相關法律法規的規定對公司該次發行事項履行了全面複核程序,並出具了《關於深圳市鉑科新材料股份有限公司向不特定對象發行可轉換公司債券所出具法律意見的複核報吿》。公司及保薦人已向深交所報送了恢復審查申請。2021年9月16日,公司收到深交所通知,決定恢復對公司該次發行的審核。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.